Name: Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 1 (en Inglés)
Price: 385528.00 COP
Availability: InStock
Author: Rahman, Atta -Ur-
ISBN: 9781608058570

portada Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 1 (en Inglés)

Formato

Libro Físico

Editorial

Bentham Science Publishers

Autor

Rahman, Atta -Ur-

Idioma

Inglés

N° páginas

318

Encuadernación

Tapa Blanda

Dimensiones

25.4 x 17.8 x 2.1 cm

Peso

0.77 kg.

ISBN13

9781608058570

Categorías

El metabolismo
Endocrinología
Farmacia y prescripción

Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 1 (en Inglés)

Rahman, Atta -Ur- (Autor) · Bentham Science Publishers · Tapa Blanda

Libro Nuevo

$ 385.528

$ 771.056

Ahorras: $ 385.528

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 23 de Julio y el Martes 06 de Agosto.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 1 (en Inglés)"

Frontiers in Clinical Drug Research - Diabetes and Obesity is an book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research - Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The first volume of this series features 6 chapters that cover a variety of topics including: -Angiotensin blockers-Agents targeting advanced glycation end products-Drugs and the peroxisome proliferator activated receptors-Topical Drugs for diabetic complications-Research on Liraglutide-Research on MicroRNAs as agents for diabetes treatment